Transcranial Magnetic Stimulation in the Treatment of Depression

Study Detail

This study is a multicenter, randomized double blind, controlled study to evaluate the safety and efficacy of H-coil deep transcranial magnetic stimulation (dTMS) as a treatment for patients with major depressive disorder who have been previously unsuccessfully treated with antidepressant medications.  

Project: 
Transcranial Magnetic Stimulation (TMS) in the Treatment of Depression
More information and application
Target audience: 

The study population will consist of patients with major depressive disorder who have failed adequate medication treatment or shown significant intolerance to medications.

Involvement: 

The study duration is 18 weeks, with a 2 week period of weaning the patient off medication, followed by 4 weeks of 5 daily treatments and 12 weeks of biweekly treatments. Mood and mental state will be carefully monitored through standard psychological scales and rating during the drug taper-down and throughout treatment.

Contact details: 

For more information on participating, call (310)206-5133 or email SHovav@mednet.ucla.edu

Review and Approval
Renewal Date: 
2012, August 10

  • Printer-friendly version
  • share

For more information on physicians and services at UCLA, please call our Physician Referral Service at (800) UCLA-MD1 or (310) 825-2631. For UCLA Neuropsychiatric and Behavioral Services, contact our ACCESS Center at (800) 825-9989 or (310) 825-9989.

Service available Monday to Friday, 8 a.m. to 5 p.m. (PST) to assist you.

In an emergency dial 911